ARTICLE | Clinical News
Afinitor everolimus regulatory update
November 8, 2010 8:00 AM UTC
Novartis said FDA approved an sNDA for Afinitor everolimus to treat subependymal giant cell astrocytomas (SEGA) associated with tuberous sclerosis (TS). In July, Novartis submitted an MAA in the EU fo...